Home › Research › Clinical trials
Effects of estrogen replacement therapy on response to tacrine in patients with Alzheimer's disease
Schneider LS, Farlow MR, Henderson VW, Pogoda JM.. Neurology, 1996-06-01
Topic: Amyloid, tau and blood-test diagnosis
Plain-language summary
Objective To examine whether estrogen replacement therapy (ERT) affects clinical and cognitive responses to tacrine in women with Alzheimer's disease (AD). Design A 30-week, randomized, double-blind, placebo-controlled, parallel-group, multicenter clinical trial of tacrine in which a subgroup of women were receiving ERT prior to randomization. Patients Women with mild to moderate-stage AD, at least 50 years of age, who were enrolled in the previously reported trial. Interventions Randomized assignment to placebo or to one of three ascending-dosage regimens of tacrine: maximum dosages of 80 mg/d, 120 mg/d or 160 mg/d. Outcome measures Alzheimer's Disease Assessment Scale-Cognitive Scale (ADASc), Clinician Interview-Based Impression of change (CIBI), Mini-Mental State Examination (MMSE), Caregiver's Impression of Change (CIC). Results Of 318 women with evaluable data 14.5% were receiving ERT. Women completing the trial taking ERT and tacrine improved more than women not receiving ERT who were randomly assigned to tacrine or to placebo as assessed by the ADASc (p < 0.01), the CIBI (p = 0.02), the CIC (p = 0.006), and the MMSE (p = 0.07). They improved significantly on the ADASc (p = 0.01) using an intent-to-treat analysis. Conclusions Prior and continuing ERT may enhance response to tacrine in women with AD. Randomized trials are needed.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Schneider, L. S., Farlow, M. R., Henderson, V. W., & Pogoda, J. M. (1996). Effects of estrogen replacement therapy on response to tacrine in patients with Alzheimer's disease. Neurology. https://doi.org/10.1212/wnl.46.6.1580
Vancouver
Schneider LS, Farlow MR, Henderson VW, Pogoda JM. Effects of estrogen replacement therapy on response to tacrine in patients with Alzheimer's disease. Neurology. 1996. doi:10.1212/wnl.46.6.1580. PMID: 8649552.
BibTeX
@article{schneider1996-8649552,
author = {Schneider, L. S. and Farlow, M. R. and Henderson, V. W. and Pogoda, J. M.},
title = {{Effects of estrogen replacement therapy on response to tacrine in patients with Alzheimer's disease}},
journal = {Neurology},
year = {1996},
doi = {10.1212/wnl.46.6.1580},
pmid = {8649552},
url = {https://doi.org/10.1212/wnl.46.6.1580}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.
Key findings
- Results Of 318 women with evaluable data 14.5% were receiving ERT.
- They improved significantly on the ADASc (p = 0.01) using an intent-to-treat analysis.
New to this subject? Start with our plain-English guide: Registered clinical trials →
Study details
- Effect size14.5%
- Evidence strengthHigh
How this study scored 59/100
Published in a leading specialty journal. Scored zero for study design and sample size because the record does not state it. We have no data on journal's citation record, times cited, citations per year, impact for its field and year, cited by studies here, still being cited, senior author's track record and institution's track record, so those were left out: it earned 36 of the 61 points we could judge it on, which is 59 out of 100.
| Component | Points | Why |
|---|---|---|
| Journal tier | 9 / 10 | Tier 2 — leading specialty journal (Neurology) |
| Journal's citation record | — / 4 | No journal record from OpenAlex — left out of this score |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 5 / 5 | Rated “high” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 1 / 5 | 1996 — older than 20 years, still counted |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 2 / 3 | Effect reported as a number, without an interval or test |
| Studied in people | 3 / 3 | Studied in people (pubmed indexes it as a clinical or observational study) |
| Randomized / blinded | 2 / 2 | Randomized and blinded or placebo-controlled (as stated in the record) |
| Times cited | — / 7 | No citation count (not found in OpenAlex) — left out of this score |
| Citations per year | — / 5 | No citation count or no year — left out of this score |
| Impact for its field and year | — / 6 | No field-weighted citation impact (OpenAlex has none yet) — left out of this score |
| Cited by studies here | — / 6 | Not yet checked against this library's citation graph — left out of this score |
| Still being cited | — / 4 | No yearly citation counts — left out of this score |
| Senior author's track record | — / 4 | Senior author's record not available — left out of this score |
| Institution's track record | — / 3 | No institution listed in OpenAlex — left out of this score |
| Multicenter collaboration | 2 / 3 | PubMed indexes it as a multicentre study |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 8649552) |
| Free to read | 0 / 2 | Behind a paywall — scores zero |
| Points | 36 / 61 | Scored on 12 of 20 parts. We have no data for the rest, so they are left out: 36 of the 61 points we could judge it on is 59 out of 100. |
| Total | 59 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
Free copy unknown: no free-copy check has an answer for this record yet. That does not mean it is paywalled.
Related
Studies in the library that share something with this one. The line above each title says what.
Related studies in Clinical trials from nearby years
Also tagged “replacement-therapy”
2 studies in the library carry the topic tag “replacement-therapy”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 2 tagged studies.